Laurion Capital Management LP Evelo Biosciences, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.81 - $5.73 $86,106 - $129,498	-22,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.12 $79,778 - $138,312	22,600 New	22,600 $111,000
Q3 2018 Nov 13, 2018	SELL	$11.93 - $14.76 $1.79 Million - $2.21 Million	-150,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$11.39 - $16.26 $1.71 Million - $2.44 Million	150,000 New	150,000 $1.77 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.